Skip to main content
Clinical Trials/NCT06983574
NCT06983574Not yet recruitingNot Applicable

Evaluating the Effectiveness of an mHealth Application to Promote Home-Based Exercise in Adults Aged 65 and Older: A Randomized Controlled Trial

PXL University College0 sites75 target enrollmentStarted: October 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
75
Primary Endpoint
MVPA

Study Overview

Brief Summary

The goal of this clinical trial is to learn if drug ABC works to evaluate the effectiveness of an mHealth application to promote home-based exercise in adults aged 65 and older. The objectives are:

Primary objective:

• To evaluate the effect of the mHealth application on increasing moderate-to-vigorous physical activity levels.

Secondary objectives:

  • To assess the impact of the mHealth application on physical fitness measures (e.g., functional capacity, strength, balance, fall risk, flexibility)
  • To assess the impact of the mHealth application on physical activity (e.g., daily steps, self-reported physical activity)
  • To examine the impact of the mHealth application on wellbeing
  • To explore the impact of the mHealth application on cognitive functioning
  • To measure user adherence and engagement with the mHealth application
  • To evaluate participant satisfaction with the mHealth application

Researchers will compare a group using an mHealth application to a group not using the application to determine whether it effectively increases physical activity.

Participants will:

  • Use the mHealth application or not for 8 weeks
  • Visit the labo 3 times in total for assessements
  • Use a wearable during the study period

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
65 Years to — (Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •65 years or older
  • •Medically stable Any existing chronic illnesses (e.g., hypertension, diabetes, or arthritis) are being effectively managed with medications or lifestyle interventions.
  • •The participant is not experiencing any recent or ongoing acute medical conditions, such as infections, recent surgeries, or injuries, that could interfere with participation in the study.
  • •No significant cognitive, mental or physical impairment that would prevent safe use of the mHealth application or performance of the exercises.
  • •Understanding and speaking Dutch
  • •Access to a smartphone and computer.

Exclusion Criteria

  • •The presence of an active lifestyle.
  • •Enrolment in other exercise programs or clinical trials that might interfere with study participation or outcomes.
  • •Any condition or circumstance deemed by a healthcare professional to pose a risk to the participant's safety or the validity of the study.

Arms & Interventions

No intervention with MIA

No Intervention

Participants in the control group will be instructed to maintain their usual physical activity, dietary habits, and sleep patterns for the 8-week study duration. They will be asked to refrain from engaging in any specialized exercise training during this time.

MIA intervention

Experimental

Participants will use the mHealth app to engage in home-based workouts aimed at promoting physical activity. The app provides exercises lasting approximately 12-15 minutes each, which participants are encouraged to perform regularly to achieve a total of at least 150 minutes of moderate-to-vigorous physical activity per week. The intervention period spans 8 weeks, during which participants should follow the app's guidance to complete the recommended workouts and track their progress. Participan

Intervention: MIA (Other)

Outcomes

Primary Outcomes

MVPA

Time Frame: From enrollment to 3 months post-intervention

Moderate-to-vigorous physical activity (MVPA) will be assessed using a wearable activity tracker, the Garmin Vivomart 5, which allows for continuous, 24/7 monitoring of physical activity. This device tracks various types of movement throughout the day, providing comprehensive data on activity levels and enabling detailed analysis of participants' physical activity patterns over time.

Secondary Outcomes

  • NPS(From enrollment to the end of intervention at 8 weeks)
  • Gait speed(From enrollment to the end of intervention at 8 weeks)
  • Quadriceps force(From enrollment to the end of intervention at 8 weeks)
  • Handgrip strength(From enrollment to the end of intervention at 8 weeks)
  • Balance(From enrollment to the end of intervention at 8 weeks)
  • Fall risk(From enrollment to the end of intervention at 8 weeks)
  • Flexibility(From enrollment to the end of intervention at 8 weeks)
  • Muscle power(From enrollment to the end of intervention at 8 weeks)
  • Daily steps(From enrollment to 3 months post-intervention)
  • IPAQ-SF(From enrollment to the end of intervention at 8 weeks)
  • ESES(From enrollment to the end of intervention at 8 weeks)
  • BREQ(From enrollment to the end of intervention at 8 weeks)
  • WHO-QoL(From enrollment to the end of intervention at 8 weeks)
  • PACES(From enrollment to the end of intervention at 8 weeks)
  • Cognitive function(From enrollment to the end of intervention at 8 weeks)
  • PSS(From enrollment to the end of intervention at 8 weeks)
  • GSQ(From enrollment to the end of intervention at 8 weeks)
  • SUS(From enrollment to the end of intervention at 8 weeks)
  • CSAT(From enrollment to the end of intervention at 8 weeks)

Investigators

Sponsor
PXL University College
Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials